CANADA LIFE ASSURANCE Co - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$8,000
-33.3%
11,2430.0%0.00%
Q4 2021$12,000
-42.9%
11,2430.0%0.00%
Q3 2021$21,000
-30.0%
11,2430.0%0.00%
Q2 2021$30,000
-25.0%
11,2430.0%0.00%
Q1 2021$40,000
+42.9%
11,2430.0%0.00%
Q4 2020$28,0000.0%11,2430.0%0.00%
Q3 2020$28,000
-24.3%
11,2430.0%0.00%
Q2 2020$37,000
+60.9%
11,243
+22.3%
0.00%
Q1 2020$23,000
-46.5%
9,1940.0%0.00%
Q4 2019$43,000
-58.3%
9,194
-47.9%
0.00%
Q2 2019$103,000
+51.5%
17,6440.0%0.00%
Q1 2019$68,000
+112.5%
17,6440.0%0.00%
Q4 2018$32,000
-42.9%
17,6440.0%0.00%
Q3 2018$56,000
+5.7%
17,6440.0%0.00%
Q2 2018$53,000
-23.2%
17,6440.0%0.00%
Q1 2018$69,000
-5.5%
17,6440.0%0.00%
Q4 2017$73,000
-33.0%
17,6440.0%0.00%
Q3 2017$109,0000.0%17,6440.0%0.00%
Q2 2017$109,000
-1.8%
17,6440.0%0.00%
Q1 2017$111,000
+16.8%
17,6440.0%0.00%
Q4 2016$95,000
-52.0%
17,644
-50.0%
0.00%
Q3 2016$198,000
+106.2%
35,288
+100.0%
0.00%
Q2 2016$96,000
-26.7%
17,6440.0%0.00%
Q1 2016$131,000
-10.9%
17,6440.0%0.00%
-100.0%
Q4 2015$147,000
+129.7%
17,644
+148.2%
0.00%
Q3 2015$64,000
-24.7%
7,1090.0%0.00%
Q2 2015$85,000
+23.2%
7,109
+10.0%
0.00%
Q1 2015$69,0006,4610.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2016
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders